Scarica l'app Stockscreener
2.80
0.36%
0.010
Pre-mercato:
2.82
0.02
+0.71%
Conduit Pharmaceuticals Inc Borsa (CDT) Ultime notizie
Conduit Pharmaceuticals (NASDAQ:CDT) Stock Price Down 0.4% – What’s Next? - Defense World
Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10 - MENAFN.com
Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10 By Stocktwits - Investing.com India
Conduit Pharmaceuticals enters joint development agreement with Manoira - TipRanks
Conduit Pharma Expands Drug Pipeline to $15B Animal Health Market Through Zero-Cost Development Deal - Stock Titan
Conduit Pharmaceuticals Sets 2025 Annual Meeting Date - TipRanks
CDT stock plunges to 52-week low, hitting $3.21 amid steep decline By Investing.com - Investing.com South Africa
CDT stock plunges to 52-week low, hitting $3.21 amid steep decline - Investing.com India
Conduit Pharmaceuticals regains Nasdaq compliance - MSN
Conduit Pharmaceuticals receives approval for Nasdaq listing - MSN
Conduit Pharmaceuticals approved to transfer listing to Nasdaq Capital Market - TipRanks
Conduit Pharmaceuticals moves to Nasdaq Capital Market By Investing.com - Investing.com India
Conduit Pharma Gains Nasdaq Capital Market Approval, Transfer Effective May 23 - Nasdaq
Conduit Pharmaceuticals moves to Nasdaq Capital Market - Investing.com Australia
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market - The Manila Times
Biotech Rising Star Conduit Pharmaceuticals Gets Green Light for Nasdaq Capital Market Transfer - Stock Titan
Conduit Pharmaceuticals meets Nasdaq listing standards By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals meets Nasdaq listing standards - Investing.com Australia
Conduit Pharmaceuticals Regains Compliance With Nasdaq's Bid Price, Equity Requirements - marketscreener.com
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance - The Manila Times
Conduit Pharmaceuticals Inc. Regains Compliance with Nasdaq Listing Requirements - Nasdaq
Upcoming Stock Splits This Week (May 19 to May 23) – Stay Invested - The Globe and Mail
Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic - MSN
Conduit Pharmaceuticals approves reverse stock split By Investing.com - Investing.com South Africa
Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic By Stocktwits - Investing.com India
Conduit Pharmaceuticals Announces Reverse Stock Split - TipRanks
Barclays PLC Buys 54,523 Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT) - Defense World
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - The Manila Times
Conduit Pharmaceuticals approves reverse stock split - Investing.com
Conduit Pharmaceuticals Inc. Announces 1-for-15 Reverse Stock Split Approval - Nasdaq
CONDUIT PHARMACEUTICALS INC. SEC 10-Q Report - TradingView
Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - The Manila Times
Conduit Pharmaceuticals Secures Korean Patent for AZD1656, Advancing Global Development Strategy for Autoimmune Disorders - Nasdaq
Conduit Pharmaceuticals Files New Patent For AZD5904 - marketscreener.com
In 2025, Will Conduit Pharmaceuticals Inc (NASDAQ: CDT) Be Bullish Or Bearish? - Stocksregister
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset - The Manila Times
Conduit Pharmaceuticals Approves Reverse Stock Split Amendments - TipRanks
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Shares Acquired by Geode Capital Management LLC - Defense World
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):